Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium [version 1; peer review: 2 approved]
The increasing threat from infection with drug-resistant pathogens is among the most serious public health challenges of our time. Formed by Wellcome in 2018, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC) is an international think tank whose aim is to inform poli...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wellcome
2025-01-01
|
| Series: | Wellcome Open Research |
| Subjects: | |
| Online Access: | https://wellcomeopenresearch.org/articles/10-5/v1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849772847096922112 |
|---|---|
| author | Paul Turner Nicholas Feasey Kate S Baker Rifat Atun H. Rogier van Doorn Francesca Chiari Andrew Jermy Timothy Jinks Matt King Souha S Kanj Mirfin Mpundu Janet Midega Stuart Reid Jamie Nunn Kamini Walia Dawn Sievert Sharon J Peacock Elizabeth Ashley Direk Limmathurotsakul Raheelah Ahmad Iruka N. Okeke Jyoti Joshi Alison Holmes |
| author_facet | Paul Turner Nicholas Feasey Kate S Baker Rifat Atun H. Rogier van Doorn Francesca Chiari Andrew Jermy Timothy Jinks Matt King Souha S Kanj Mirfin Mpundu Janet Midega Stuart Reid Jamie Nunn Kamini Walia Dawn Sievert Sharon J Peacock Elizabeth Ashley Direk Limmathurotsakul Raheelah Ahmad Iruka N. Okeke Jyoti Joshi Alison Holmes |
| author_sort | Paul Turner |
| collection | DOAJ |
| description | The increasing threat from infection with drug-resistant pathogens is among the most serious public health challenges of our time. Formed by Wellcome in 2018, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC) is an international think tank whose aim is to inform policy and change the way countries track, share, and analyse data relating to drug-resistant infections, by defining knowledge gaps and identifying barriers to the delivery of global surveillance. SEDRIC delivers its aims through discussions and analyses by world-leading scientists that result in recommendations and advocacy to Wellcome and others. As a result, SEDRIC has made key contributions in furthering global and national actions. Here, we look back at the work of the consortium between 2018-2024, highlighting notable successes. We provide specific examples where technical analyses and recommendations have helped to inform policy and funding priorities that will have real-world impact on the surveillance and epidemiology of infections with drug-resistant pathogens. |
| format | Article |
| id | doaj-art-8d0866cad8cf478dace580cd98d4ceaa |
| institution | DOAJ |
| issn | 2398-502X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wellcome |
| record_format | Article |
| series | Wellcome Open Research |
| spelling | doaj-art-8d0866cad8cf478dace580cd98d4ceaa2025-08-20T03:02:14ZengWellcomeWellcome Open Research2398-502X2025-01-011010.12688/wellcomeopenres.23494.125914Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium [version 1; peer review: 2 approved]Paul Turner0https://orcid.org/0000-0002-1013-7815Nicholas Feasey1https://orcid.org/0000-0003-4041-1405Kate S Baker2Rifat Atun3H. Rogier van Doorn4https://orcid.org/0000-0002-9807-1821Francesca Chiari5Andrew Jermy6Timothy Jinks7Matt King8Souha S Kanj9https://orcid.org/0000-0001-6413-3396Mirfin Mpundu10Janet Midega11Stuart Reid12Jamie Nunn13Kamini Walia14Dawn Sievert15Sharon J Peacock16Elizabeth Ashley17https://orcid.org/0000-0002-7620-4822Direk Limmathurotsakul18https://orcid.org/0000-0001-7240-5320Raheelah Ahmad19https://orcid.org/0000-0002-4294-7142Iruka N. Okeke20https://orcid.org/0000-0002-1694-7587Jyoti Joshi21Alison Holmes22https://orcid.org/0000-0001-5554-5743University of Oxford Nuffield Department of Medicine, Oxford, England, UKDepartment of Clinical Sciences,, Liverpool School of Tropical Medicine, Liverpool, UKGenetics, University of Cambridge, Cambridge, UKHarvard School of Public Health, Boston, Massachusetts, USAUniversity of Oxford Nuffield Department of Medicine, Oxford, England, UKDrug resistant infections Priority Programme, Wellcome Trust, London, UKGerminate, Germinate Science Consulting Ltd, Suffolk, UKDrug resistant infections Priority Programme, Wellcome Trust, London, UKARCTA solutions Ltd, Hampshire, UKDivision of Infectious Diseases, Internal Medicine Department, and Center for Infectious Diseases Research, American University of Beirut Medical Center, Beirut, LebanonReAct Africa, Lusaka, ZambiaDrug resistant infections Priority Programme, Wellcome Trust, London, UKThe Royal Veterinary College, London, England, UKLondon School of Hygiene & Tropical Medicine, University of London, London, England, UKIndian Council of Medical Research, New Delhi, Delhi, IndiaAntimicrobial Resistance Coordination and Strategy Unit, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atanta, Georgia, USAMedicine, University of Cambridge, Cambridge, UKUniversity of Oxford Nuffield Department of Medicine, Oxford, England, UKMahidol Oxford Tropical Medicine Research Unit, Bangkok, Bangkok, ThailandNIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UKDepartment of Pharmaceutical Microbiology, University of Ibadan, Ibadan, Oyo, NigeriaInternational Centre for AMR Solutions, Copenhagen, DenmarkNIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UKThe increasing threat from infection with drug-resistant pathogens is among the most serious public health challenges of our time. Formed by Wellcome in 2018, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC) is an international think tank whose aim is to inform policy and change the way countries track, share, and analyse data relating to drug-resistant infections, by defining knowledge gaps and identifying barriers to the delivery of global surveillance. SEDRIC delivers its aims through discussions and analyses by world-leading scientists that result in recommendations and advocacy to Wellcome and others. As a result, SEDRIC has made key contributions in furthering global and national actions. Here, we look back at the work of the consortium between 2018-2024, highlighting notable successes. We provide specific examples where technical analyses and recommendations have helped to inform policy and funding priorities that will have real-world impact on the surveillance and epidemiology of infections with drug-resistant pathogens.https://wellcomeopenresearch.org/articles/10-5/v1Antimicrobial resistance surveillanceeng |
| spellingShingle | Paul Turner Nicholas Feasey Kate S Baker Rifat Atun H. Rogier van Doorn Francesca Chiari Andrew Jermy Timothy Jinks Matt King Souha S Kanj Mirfin Mpundu Janet Midega Stuart Reid Jamie Nunn Kamini Walia Dawn Sievert Sharon J Peacock Elizabeth Ashley Direk Limmathurotsakul Raheelah Ahmad Iruka N. Okeke Jyoti Joshi Alison Holmes Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium [version 1; peer review: 2 approved] Wellcome Open Research Antimicrobial resistance surveillance eng |
| title | Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium [version 1; peer review: 2 approved] |
| title_full | Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium [version 1; peer review: 2 approved] |
| title_fullStr | Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium [version 1; peer review: 2 approved] |
| title_full_unstemmed | Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium [version 1; peer review: 2 approved] |
| title_short | Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium [version 1; peer review: 2 approved] |
| title_sort | insights of sedric the surveillance and epidemiology of drug resistant infections consortium version 1 peer review 2 approved |
| topic | Antimicrobial resistance surveillance eng |
| url | https://wellcomeopenresearch.org/articles/10-5/v1 |
| work_keys_str_mv | AT paulturner insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT nicholasfeasey insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT katesbaker insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT rifatatun insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT hrogiervandoorn insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT francescachiari insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT andrewjermy insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT timothyjinks insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT mattking insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT souhaskanj insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT mirfinmpundu insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT janetmidega insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT stuartreid insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT jamienunn insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT kaminiwalia insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT dawnsievert insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT sharonjpeacock insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT elizabethashley insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT direklimmathurotsakul insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT raheelahahmad insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT irukanokeke insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT jyotijoshi insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved AT alisonholmes insightsofsedricthesurveillanceandepidemiologyofdrugresistantinfectionsconsortiumversion1peerreview2approved |